Gilead Says Atty's Lie Kills Merck IP Behind $200M Jury Win
Two patents behind Merck's $200 million jury trial victory last week are unenforceable, rival Gilead told a California federal judge at a follow-on bench trial Wednesday, saying an attorney who prosecuted...To view the full article, register now.
Already a subscriber? Click here to view full article